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Gel dosimeters have unique advantages in comparison with other dosimeters. Until now,
these gels have been used in different radiotherapy techniques as a reliable dosimetric
tool. Because dose distribution measurement is an important factor for appropriate
treatment planning in different radiotherapy techniques, in this study, we evaluated the
ability of the N-isopropylacrylamide (NIPAM) polymer gel to record the dose distribution
resulting from the mixed neutron-gamma field of boron neutron capture therapy (BNCT).
In this regard, a head phantom containing NIPAM gel was irradiated using the Tehran
Research Reactor BNCT beam line, and then by a magnetic resonance scanner. Eventually,
the R2 maps were obtained in different slices of the phantom by analyzing T2-weighted
images. The results show that NIPAM gel has a suitable potential for recording three-
dimensional dose distribution in mixed neutron-gamma field dosimetry.
Copyright © 2016, Published by Elsevier Korea LLC on behalf of Korean Nuclear Society. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Boron neutron capture therapy (BNCT) is a chemically tar-
geted radiotherapy that uses the high neutron capture cross
section of 10B at thermal neutron energies to achieve a
preferential dose increase within the tumor volume. In this
radiotherapy technique, boron is first selectivelyA. Khajeali).
arnegin et al., Investiga
N-Isopropylacrylamide
sevier Korea LLC on beha
mons.org/licenses/by-ncaccumulated in the tumor cells by a tumor-specific boron
carrier, and then the patient is exposed with a neutron beam
from a nuclear reactor or an accelerator. A variety of boron
delivery agents have been investigated to date, including
amino acids, porphyrins, nanoparticles, polyamines,
biochemical precursors, DNA-binding agents, sugars, anti-
sense agents, peptides, proteins, monoclonal antibodies, andtion of Dose Distribution in Mixed Neutron-Gamma Field of
Gel, Nuclear Engineering and Technology (2016), http://
lf of Korean Nuclear Society. This is an open access article under
-nd/4.0/).
Table 1e Elemental composition of NIPAMgel and Kerma
factor for each element.
Elements Weight percent
H 10.81
C 6.51
N 1.65
O 80.42
P 0.29
Cl 0.33
NIPAM, N-isopropylacrylamide.
Nu c l e a r E n g i n e e r i n g a n d T e c h n o l o g y x x x ( 2 0 1 6 ) 1e72liposomes. However, there are only two boron delivery
agents available for clinical BNCT trials for malignant gli-
oma: 10B-enriched boronophenylalanine and biodistribution
of sodium borocaptate. These drugs are distributed through
passive diffusion from the blood to tumor tissues via the
disrupted bloodebrain barrier. The boron concentration in a
normal brain with an intact bloodebrain barrier remains
minimal, whereas the tumor 10B concentration is related to
both the tumor vessel density and the blood 10B level [1].
In BNCT, the energy of the neutron beam is chosen with
respect to the depth of the tumor. Thus, for treating superficial
tumors such as melanoma and meningioma, a thermal
neutron (E< 0.5 eV) or a mixed thermaleepithermal neutron
beam is used, whereas epithermal neutron beams
(0.5 eV< E < 10 keV) are used for the treatment of deep-seated
tumors such as glioblastoma multiforme. Epithermal neu-
trons are thermalized in tissue, and when they reach the
boron-labeled tumor cells, their capture reaction probability
by 10B isotopes is thus increased. This reaction produces alpha
and lithiumparticles that have high linear energy transfer and
release their energy at the cellular level. In addition to the
dose resulting from the boron neutron capture reaction, there
are three other dose components in BNCT [2]:
1. The gamma dose from neutron beam and 1H(nth, g)
2H
reaction
2. The dose resulting from thermal neutron capture in ni-
trogen [14N(nth, p)
14C]
3. Fast and epithermal neutrons dose from the 1H(n,n0)2H
reaction
Aswithother radiotherapy techniques, thegoal ofBNCT is to
deliver themaximumdose to the tumorandthe leastdose to the
normalhealthy tissue for obtaining ahighcure rate and limiting
radiation toxicity. This goal necessitates the measurement of
radiation dose and exact knowledge of radiation effects.
Therefore, understanding the radiation field characteristics
through measurement of the radiation dose at the desired
location of the body is very important. Radiation dosimetry is a
process to quantitatively measure the energy deposited in
various organs using dosimetric systems with the highest level
of accuracy. Dosimetry for BNCT is much more complicated
than other radiotherapies because of the various dose compo-
nentswithdifferent relativebiologicaleffectiveness.Commonly
in the clinical dosimetry of BNCT, the dose from thermal
neutronreactionswith 14Nand 10B is calculatedusing thekerma
approach, after measuring the thermal neutron flux using the
neutron activation technique [2]. Moreover, the dose resulting
from fast and epithermal neutrons andphotons are determined
using the dual ionization chamber technique as described in
International Commission on Radiation Units (ICRU) Report 45
[2]. These techniques have several drawbacks [3]:
1. These methods are very time consuming.
2. Thermalneutronandborondosesarenotmeasureddirectly,
and themeasured thermalneutronflux shouldbemultiplied
by the appropriate kerma coefficient for dose evaluation.
3. At least two dosimetry methods are required for calcula-
tion of total absorbed dose.
4. Ionization chambers require several correction factors.Please cite this article in press as: E. Bavarnegin et al., Investiga
Boron Neutron Capture Therapy using N-Isopropylacrylamide
dx.doi.org/10.1016/j.net.2016.07.012To date, numerous studies have been conducted to over-
come these drawbacks and improve the absorbed radiation
dose measurement in BNCT. In this context, several dosime-
ters have been evaluated for acceptable application in BNCT
dosimetry, considering all advantages and disadvantages,
including GafChromic films, Thermoluminescent Dosimeters
(TLDs), alanine detectors, and gel dosimeters [3e6]. The
radiation-sensitive gels have unique advantages in compari-
son with other dosimeters. In general, they are tissue equiv-
alent phantom dosimeters capable of measuring three-
dimensional (3D) dose distributions with high spatial resolu-
tion [7]. To date, several attempts have been made to use gel
dosimeters in BNCT dosimetry [8e13]. The results of such
studies indicate that dosimeters have significant potential for
dose measurement in BNCT.
Themain objective of this study is to evaluate the potential
ofN-isopropylacrylamid (NIPAM) gel for recording the 3D dose
distribution in Tehran Research Reactor (TRR) BNCT beam
line. In this regard, NIPAM gel was irradiated with the neutron
beam in an acrylic ellipsoidal head phantom and then imaged
by a magnetic resonance (MR) scanner. Subsequently, the T2-
weighted images were obtained from different slices of the
phantom containing the gel. These images were analyzed
using the Matlab software in order to extract the relaxation
rate (R2) values. Finally, it was shown that NIPAM gel as a 3D
dosimeter has suitable potential for applying in the mixed
neutron-gamma field of BNCT.2. Materials and methods
2.1. Gel preparation
A NIPAM gel dosimeter was prepared using the method pro-
posed by Senden et al [14], inside of a fume hood, and under
normal atmospheric conditions. According to this method,
gelatin (300 BloomTypeA; Sigma-Aldrich) was added to 80% of
deionized water. While the gelatin was dissolving, the tem-
perature was increased to 50C, and then N-N0-methylene-bis
acrylamide (BIS) (Sigma-Aldrich) was added to the solution as
a crosslinker agent for the radiation-induced polymerization
process. Following BIS, N-isopropylacrylamide (NIPAM;
Sigma-Aldrich) was added to the gelatineBIS mixture after
cooling the temperature down to 37C. When the monomers
were completely dissolved, a solution of the antioxidant tet-
rakis(hydroxymethyl)phosphonium chloride (THPC) with the
remaining water was prepared, and added to the solution at
35C. All chemicals were sourced from Sigma-Aldrich, andtion of Dose Distribution in Mixed Neutron-Gamma Field of
Gel, Nuclear Engineering and Technology (2016), http://
Fig. 1 e The head phantom containing NIPAM gel. NIPAM,
N-isopropylacrylamide.
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presented in Table 1.
Eventually, the prepared gel was poured into an acrylic
ellipsoidal head phantom (Fig. 1). The head phantom pre-
sented here is an ellipsoidal head phantom close to the Snyder
head model [15,16].
As light can cause polymerization in gel, the gels were
completely sealed in aluminum foil and then transferred to a
refrigerator for solidification [14].
2.2. Irradiation in TRR BNCT beam line
As previously noted, one of the important sources for BNCT is
a nuclear reactor. There are several nuclear reactors world-
wide that have been used for BNCT [17e19]. The feasibility of
the TRR as a neutron source for BNCT has been demonstrated,
and many attempts have been conducted to produce a suit-
able BNCT beam [20e22]. The thermal column of the TRR has
beenmodified to provide an appropriate neutron beam for use
in the BNCT treatment method [22,23]. The criteria for a
qualified neutron beam for BNCT are given by the Interna-
tional Atomic Energy Agency [2]. Table 2 shows theTable 2 e TRR in-air BNCT parameters.
Reactor Power (MW) 4thermal

 109 ncm2$
IAEA e >1
RA-3 10 9
JRR-2 10 1/1
JRR-4 (mode 1) 3/5 2
JRR-4 (mode 2) 3/5 0/6
TRR 5 0.56 ± 0.09
Note. From “Design of an epithermal neutron beam for BNCT in therm
Rahmani, 2014, Ann. Nucl. Energy, 68, p. 234e238. Copyright 2014, Elsevier
beam for BNCT at Tehran Research Reactor,” by Y. Kasesaz, H. Khalafi,
Amini, 2014, Appl. Radiat. Isot., 94, p. 149e151. Copyright 2015, Elsevier Lt
IAEA, International Atomic Energy Agency; JRR, ; TRR, Tehran Research R
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dx.doi.org/10.1016/j.net.2016.07.012recommended beam parameters and measured values of the
TRR in-air beam parameters in comparison with other BNCT
facilities around the world [2,22]. As shown in Table 2, TRR
BNCT beam parameters are close to those of other BNCT fa-
cilities and satisfy the International Atomic Energy Agency
criteria to a reasonable approximation [21].
The phantom containing gel dosimeter was irradiated in
front of the TRR thermal BNCT beam line at a reactor power of
3 MW. The thermal column is about 3 m in length with a wide
square shape cross section of 1.2 1.2 m2. It is filled with
removable graphite blocks. In order to produce a proper
thermal neutron beam, the configuration of graphite blocks
has been rearranged in such a way that it is possible to
create a 2.6 0.3 0.3 m3 empty channel. Additionally, a
30 30 12 cm3 lead block as a gamma shield and a
collimator have been constructed and installed in the beam
line (Fig. 2).2.3. MR imaging
In polymer gel dosimetry, upon irradiation, radiation-induced
polymerization occurs in the dosimeter, limiting the move-
ment of water molecules, and increasing the R2 values as a
function of the absorbed radiation dose. Therefore, MR im-
aging is a commonly used technique in reading out the poly-
mer gel dosimeters [7]. In this study, the phantom containing
NIPAM polymer gel were imaged by a 1.5-T Siemens MR
scanner 24 hours after irradiation. Because temperature fluc-
tuations affect the dosimeter responses, the phantom was
maintained at room temperature level and was finally imaged
inside the head coil of the scanner [24].
Eventually, T2-weighted images in multiple spineecho
sequence were obtained, from five slices of the different sec-
tions of the phantom, and one slice from the center of the
vials. Other characteristics of the MRI protocol used are pre-
sented in Table 3.
In order to obtain the R2map, theMR imageswere analyzed
by code written using the MATLAB software (2014).3. Results
After irradiation and MR imaging of the phantom containing
gel, the R2 values were obtained by analyzing the MR images

Cadmium ratio _Dg
fthermal

 1013Gy cm2n

<2
4100 1/73
64 1/21
2/5 5
13/5 3/24
180 2/8
al column of Tehran research reactor,” by Y. Kasesaz, H. Khalafi, F.
Ltd. With permission. “Design and construction of a thermal neutron
F. Rahmani, A. Ezzati, M. Keyvani, A. Hossnirokh, M.A. Shamami, S.
d. With permission.
eactor.
tion of Dose Distribution in Mixed Neutron-Gamma Field of
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Fig. 2 e The Tehran Research Reactor (TRR) thermal boron neutron capture therapy (BNCT) beam line.
Nu c l e a r E n g i n e e r i n g a n d T e c h n o l o g y x x x ( 2 0 1 6 ) 1e74using a code written in MATLAB. In order to evaluate the dose
response of the gel in the irradiated phantom, the extracted R2
maps from the T2-weighted MR images were normalized to
the maximum R2 value, and the relative dose response of the
gel in the different slices of the phantomwas obtained (Fig. 3).Table 3 e Themagnetic resonance imaging (MRI) protocol
used for scanning gel dosimeters.
Sequence T2-weighted multiple spin
echoes
Matrix size 512 512
Slice thickness (mm) 5
Repetition time (TR) (ms) 4000
Echo time (TE) (ms) 20
Inter echo time spacing (ms) 20
Number of echoes 32
Number of accusation 1
Fig. 3 e Relative dose response of N-isopropylacrylamide (NIPA
normalized to the maximum R2 value.
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dx.doi.org/10.1016/j.net.2016.07.012The R2 profiles along and perpendicular to the beam line at
the center of each phantom slice are presented in Fig. 4.
The figure shows that the R2 value decreases with
increasing depth in different sections of the head phantom.
Also, the dose profiles perpendicular to the beam line show
very little variation, indicating sufficient beam uniformity.
NIPAMpolymer gel was first introduced by Senden et al [14]
as a lower toxicity polymer gel dosimeter in 2006. Studies
carried out to investigate the basic dosimetric characteristics
of NIPAM gel have shown that the gel's response in photon
irradiation is reproducible, with energy and dose rates being
independent. It was also shown that NIPAM gel is tissue-
equivalent in terms of electron and mass density [25]. As the
elemental composition of the dosimeter is themost important
parameter in tissue equivalency, especially in neutron
dosimetry, in Khajeali et al's [13] study, the elemental
composition of NIPAM gel was compared to the adult brainM) gel in different slices of the head phantom. Results are
tion of Dose Distribution in Mixed Neutron-Gamma Field of
Gel, Nuclear Engineering and Technology (2016), http://
Fig. 4 e R2 profiles along (left) and perpendicular (right) to the beam line at the center of each phantom slice. Results are
normalized to the maximum R2 value.
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Nu c l e a r E n g i n e e r i n g a n d T e c h n o l o g y x x x ( 2 0 1 6 ) 1e76tissue, and it was found that the gel could be considered as a
tissue equivalent phantom-dosimeter in BNCT.
Gel dosimeters including Fricke and polymer were first
used in BNCT dosimetry by Gambarini et al [8] and Farajollahi
et al [26], respectively. So far, Fricke gels have been more
frequently used in BNCT to measure different dose compo-
nents [27e29]. These dosimeters have shown promising re-
sults in this regard, but they have several drawbacks
associated with ferrous and ferric ion diffusion following
irradiation, which lead to a decrease in the spatial stability in
measuring dose distribution [3]. Unlike Fricke, polymer gels
have high stability in recording 3D dose information. In 2000,
Farajollahi et al [26], by irradiating BANG polymer gel con-
taining different amounts of 10B in front of the epithermal
BNCT beam, showed that this dosimeter had a suitable po-
tential in recording the enhanced dose owing to thermal
neutron and 10B reaction [26]. Subsequently, BANG-3 and
MAGIC polymer gel were irradiated in an epithermal neutron
beam from a Finnish BNCT facility at the FiR 1 nuclear reactor,
and their responses were compared with the calculated radi-
ation dose by simulation codes [12,30]. Although the results of
these studies supported the potential of polymer gels in BNCT
dosimetry, their toxicity formulation was the main limitation.
The current study takes advantage of NIPAM gel, which is a
polymer gel dosimeter with less toxicity than other polymer
gels, for determination of dose distribution in BNCT. In order
to determine the dose distribution resulting from the TRR
BNCT beam, a head phantom containing the NIPAM gel was
irradiated in the beam and then imaged by an MR scanner.
The R2 map and the relative dose response of the gel in the five
slices of the phantomwere obtained. The R2 profiles along the
beam show how to decrease the dose resulting from the beam
by increasing the depth in different sections of the irradiated
head phantom. There is a direct relation between R2 values
and dose. A high R2 value corresponds to high dose and high
polymerization, which results in increasing the dose value.
With an increase in the depth of phantom, the neutron flux
was attenuated and so there was a decrease in the dose and R2
values.
As can be seen in Fig. 4, there is about 10% difference be-
tween the dose response of the gel at the start and end points
of the phantom. The dose profiles perpendicular to the beam
line show little variation, confirming the uniformity of the TRR
BNCT beam line.4. Conclusion
The results show that NIPAM gel as a lower toxicity polymer
gel and a tissue equivalent phantom dosimeter, is suitable for
recording 3D dose distribution in mixed neutron-gamma field
dosimetry. Moreover, this gel can be a reliable tool for over-
coming the drawbacks associated with conventional BNCT
dosimetry, and useful in dosimetric verification of BNCT
treatment planning because of its capabilitiesdespecially its
ability to record dose in 3D with high spatial resolution.
Further studies are required to investigate the use of NIPAM
gel in clinical situations of BNCT, and its capacity for obtaining
dose information in tumor and nontumoral surrounding
tissues.Please cite this article in press as: E. Bavarnegin et al., Investiga
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